Patient satisfaction with antipsychotic treatment as a measure of treatment effectiveness: Results from a longitudinal study of French patients with schizophrenia

被引：0
|
作者：
Gasquet, I
Tcherny-Lessenot, S
Lepine, JP
Falissard, B
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S420 / S421
页数：2
相关论文
共 50 条
  • [1] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: French results from the pan European soho study
    Gasquet, Isabelle
    Tcherny-Lessenot, Stephanie
    Chartier, Florence
    Lepine, Jean-Pierre
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S261 - S261
  • [2] Determinants of treatment satisfaction of schizophrenia patients: Results from the ESPASS study
    Nordon, Clementine
    Rouillon, Frederic
    Barry, Caroline
    Gasquet, Isabelle
    Falissard, Bruno
    SCHIZOPHRENIA RESEARCH, 2012, 139 (1-3) : 211 - 217
  • [3] Effectiveness and patient satisfaction with 6 months tadalafil treatment: Results from the DETECT study
    Roumeauere, T.
    Verheyden, B.
    Bitton, A.
    Roos, E.
    Belger, M.
    Schmitt, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 78 - 78
  • [4] Effectiveness of antipsychotic treatment in never treated patients with schizophrenia: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D.
    Suarez, D.
    Gasquet, I.
    Haro, J. M.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S131 - S132
  • [5] Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients
    Jaeger, M.
    Riedel, M.
    Obermeier, M.
    Schennach-Wolff, R.
    Seemueller, F.
    Messer, T.
    Laux, G.
    Pfeiffer, H.
    Naber, D.
    Schmidt, L. G.
    Gaebel, W.
    Klosterkoetter, J.
    Heuser, I.
    Kuehn, K.-U.
    Lemke, M. R.
    Ruether, E.
    Klingberg, S.
    Gastpar, M.
    Bottlender, R.
    Moeller, H.-J.
    SCHIZOPHRENIA RESEARCH, 2010, 118 (1-3) : 183 - 188
  • [6] A Longitudinal Study on the Impact of Antipsychotic Treatment on Serum Leptin in Schizophrenia
    Venkatasubramanian, Ganesan
    Chittiprol, Seetharamaiah
    Neelakantachar, Narendran
    Shetty, Taranath K.
    Gangadhar, Bangalore N.
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (06) : 288 - 292
  • [7] The Patient Assessment Questionnaire: Initial validation of a measure of treatment effectiveness for patients with schizophrenia and schizoaffective disorder
    Mojtabai, Ramin
    Corey-Lisle, Patricia K.
    Ip, Edward Hak-Sing
    Kopeykina, Irina
    Haeri, Sophia
    Cohen, Lisa Janet
    Shumaker, Sally
    PSYCHIATRY RESEARCH, 2012, 200 (2-3) : 857 - 866
  • [8] The effectiveness of the atypical antipsychotic aripiprazole versus standard of care treatment in patients with schizophrenia: The star study
    Kerwin, R.
    L'Italien, G.
    Hanssens, L.
    Marcus, R. N.
    McQuade, R.
    Carson, W. H.
    Bewen, J. -N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S283 - S283
  • [9] Antipsychotic Treatment in a Patient With Schizophrenia Undergoing Hemodialysis
    Batalla, Albert
    Vera, Manel
    Torra, Merce
    Parellada, Eduard
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (01) : 92 - 94
  • [10] ANTIPSYCHOTIC MONOTHERAPY TREATMENT WITH ATYPICALS IN OUTPATIENTS WITH SCHIZOPHRENIA: RESULTS FROM A NATURALISTIC OBSERVATIONAL STUDY
    Novick, Diego
    Ascher-Svanum, Haya
    Brugnoli, R.
    Bertsch, J.
    Hong, Jihyung
    Maria Haro, Josep
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 316 - 317
12345